Psychoneuroendocrinology and suicidal behaviour;Psiconeuroendocrinologia e comportamento suicida

Jornal Brasileiro de Psiquiatria

Volumn 54, Issue 2, 2005, Pages 138-144

  Corrêa, Humberto ^a   Machado Viana, Melissa ^a   Romano Silva, Marco Aurélio ^a   Duval, Fabrice ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Fundation Pour la Recherche em Neurocience Appliqué à la Psychiatrie   (Brazil)

Author keywords

Psychoneuroendocrinology; Serotonin; Suicidal behaviour

Indexed keywords

APOMORPHINE; CLONIDINE; CORTICOTROPIN; DEXAMETHASONE; FENFLURAMINE; HYDROCORTISONE; NEUROHORMONE; PROLACTIN;

DOPAMINERGIC SYSTEM; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MONOAMINERGIC SYSTEM; NEUROENDOCRINOLOGY; NORADRENERGIC SYSTEM; PROLACTIN BLOOD LEVEL; REVIEW; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR;

EID: 24144437110     PISSN: 00472085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Abel KM, O'Keane V, Murray RM, Cleare AJ. Serotonergic function and depressive symptomatology in schizophrenia and major depression. Psychoneuroendocrinology, 22: 539-48, 1997.
2. Abel KM, Cleare AJ. Peripheral hormonal responses to D-fenfluramine as a probe of central serotonergic function in humans. Psychopharmacology, 142: 68-72, 1999.
3. APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry, 144: 1253-62, 1987.
4. Arato M, Rihmer Z, Banki CM, Grof P. The relationships of neuroendocrine tests in endogenous depression. Prog Neuropsychopharmacol Biol Psychiatry, 7: 715-8, 1983.
5. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry, 33: 1193-7, 1976.
6. Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci, 836: 158-81, 1997.
7. Brown RP, Mason B, Stoll P, Brizer D, Kocsis J, Stokes PE, Mann JJ. Adrenocortical function and suicidal behavior in depressive disorders. Psychiatr Res, 17: 317-23, 1986.
8. Brunner J, Bronisch T. Neurobiological correlates of suicidal behavior. Fortschr Neurol Psychiatr, 67: 391-412, 1999.
9. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lorh N, Steiner M, De Vigne JP, Ypung E. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry, 38: 15-22, 1981.
10. Cleare AJ, McGregor A, Chambers SM, Dawling S, O'Keane V. Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. Neuroendocrinology, 4: 65-9, 1996.
11. Coccaro EF, Siever LJ, Klar H, Rubenstein K, Benjamin E, Davis KL. Diminished prolactin responses to repeated fenfluramine challenge in man. Psychiatry Res, 22: 257-9, 1987.
12. Correa H, Duval F, Mockani MC, Bailey P, Volpe FM, Macher JP. Disfunção noradrenérgica e ansiedade em pacientes com depressão maior. J Bras Psiquiatr, 48: 159-62, 1999.
13. Correa H, Duval F, Mokrani M, Bailey P, Tremeau F, Staner L, Diep TS, Hode Y, Crocq MA, Macher JP. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res, 93: 189-99, 2000.
14. Correa H, Duval F, Mokrani MC, Bailey P, Tremeau F, Staner L, Diep TS, Crocq MA, Macher JP. Serotonergic function and suicidal behavior in schizophrenia. Schizophr Res, 56: 75-85, 2002.
15. Corrigan MH, Gillette GM, Quade D, Garbutt JC. Panic, suicide, and agitation: independent correlates of the TSH response to TRH in depression. Biol Psychiatry, 31: 984-92, 1992.
16. Coryell W, Schlesser MA. Suicide and the dexamethasone suppression test in unipolar depression. Am J Psychiatry, 138: 1120-1, 1981.
17. Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry, 158: 748-53, 2001.
18. Cowen PJ. Cortisol, serotonin and depression: all stressed out? Br J Psychiatry, 180: 99-100, 2002.
19. Dinan TG, Scott LV. The influence of cortisol on spontaneous and 5HT stimulated prolactin release in man. J Basic Clin Physiol Pharmacol, 7: 45-56, 1996.
20. Duval F. Hormones thyroïdiennes et dépression. In: Éditorial Assistance et Ardix Médical, eds. Les Aspects Neuroendocriniens des Troubles de l'Humeur. Vélizy: Doin; 1995.
21. Duval F, Mockrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology, 24: 695-712, 1999.
22. Duval F, Mokrani MC, Bailey P, Valdebenito M, Crocq MA, Diep TS, Macher JP. Dopamine function in men and bipolar depression. Biol Psychiatry, 47: 73S, 2000a.
23. Duval F, Correa H, Mockani MC, Crocq MA, Bailey P, Diep TS, Macher JP. Serotonergic and noradrenergic function in depression: clinical correlates. Dialogues Clinical Neuroscience, 2: 299-308, 2000b.
24. Duval F, Mokrani MC, Corrêa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology, 26: 521-37, 2001.
25. 2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology, 22: 477-91, 1997.
26. Goichot B, Brandenberger G, Saini J, Wittersheim G, Follenius M. Nyctohemeral patterns of thyroid hormones and their relationship with thyrotropin variations and sleep structure. J Endocrinol Invest, 17: 181-7, 1994.
27. Hugues JN, Reinberg A, Lagoguey M, Modigliani E, Sebaoun J. Les rythmes biologiques de la sécrétion thyréotrope. Ann Medice Interne, 134: 84-94, 1983.
28. Holsboer F. The hypothalamic-pituitary-adrenocortical system. In: Paykel ES, ed. Handbook of Affective Disorders. Churchill Livingstone, p. 267-87, Edinburg, 1992.
29. Holsboer F. Neuroendocrinology of mood disorder. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the Fourth Generation of Progress. Raven Press, p. 957-69, New York, 1995.
30. Kavoussi RJ, Hauger RL, Coccaro EF. Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors. Biol Psychiatry, 45: 295-9, 1999.
31. Korner A, Kirkegaard C, Larsen JK. The thyrotropin response to thyrotropin-releasing hormone as a biological marker of suicidal risk in depressive patients. Acta Psychiatr Scand, 76: 355-8, 1987.
32. Lal S. Apomorphine in the evaluation of dopaminergic function in man. Prog Neuropsychopharmacol Biol Psychiatry, 12: 117-64, 1988.
33. Lewis CF, Tandon R, Shipley JE, DeQuardo JR, Jibson M, Taylor SF, Goldman M. Biological predictors of suicidality in schizophrenia. Acta Psychiatr Scand, 94: 416-20, 1996.
34. Linkowski P, Van Wettere JP, Kerkhofs M, Gregoire F, Brauman H, Mendlewicz J. Violent suicidal behavior and the thyrotropin-releasing hormone-thyroid-stimulating hormone test: a clinical outcome study. Neuropsychobiology, 12: 19-22, 1984.
35. Loosen PT, Prange AJ. Serum thyrotropin response to throtropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry, 139: 405-16, 1982.
36. Maes M, d'Hondt P, Suy E, Minner B, Vandervorst C, Raus J. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry, 15: 781-90, 1991.
37. Malone KM, Corbitt EM, Li S, Mann JJ. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Brit J Psychiatry, 168: 324-9, 1996.
38. Matussek N. Alpha-adrenoreceptors and depression. Cesk Psychiatry, 85: 26-30, 1989.
39. Meltzer HY, Kolakowska T, Fang VS, Fogg L, Robertson A, Lewine R, Strahilevitz M, Busch D. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms. Arch Gen Psychiatry, 41: 512-9, 1984.
40. Meltzer HY, Lowy MT. The serotonin hypothesis of depression. In: Meltzer HY, ed. Psychopharmacology: the Third Generation of Progress. Raven Press, p. 513-26, New York, 1987.
41. Meltzer HY, Maes M. Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men. Biol Psychiatry, 38: 310-8, 1995.
42. Modestin J, Ruef C. Dexamethasone suppression test (DST) in relation to depressive somatic and suicidal manifestations. Acta Psychiatr Scand, 75: 491-4, 1987.
43. Mokrani MC, Duval F, Crocq MA, Bailey PE, Macher JP. Multihormonal responses to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology, 25: 741-52, 2000.
44. Monteleone P, Tortorella A, Borriello R, Cassandro P, Maj M. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study. Biol Psychiatry, 45: 1606-11, 1999.
45. Nelson JC, Davis JM. DST studies in psychotic depression: a meta-analysis. Am J Psychiatry, 154: 1497-503, 1997.
46. Norman WH, Brown WA, Miller IW, Keitner GI, Overholser JC. The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand, 81: 120-5, 1990.
47. O'Keane V, Dinan TG. Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry, 148: 1009-15, 1991.
48. Pfeffer C, Stokes P, Shindledecker R. Suicidal behavior and hypothalamic-pituitary-adrenocortical axis in child psychiatric inpatients. Biol Psychiatry, 29: 909-17, 1991.
49. Pitchot W, Hansenne M, Moreno AG, Ansseau M. Suicidal behavior and growth hormone response to apomorphine test. Biol Psychiatry, 31: 1213-9, 1992.
50. Pitchot W, Ansseau M, Gonzales Moreno A, Wauthy J, Hansenne M, von Frenckell R. Relationship between alpha-2-noradrenergic function and suicidal behavior in depressed patients. Psychiatry Res, 52: 115-23, 1994.
51. Pitchot W, Ansseau M, Gonzalez Moreno A, Lembreghts M, Hansenne M, Wauthy J, Reel C, Jammaer R, Papart P, Sulon J. The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry, 2: 91-2, 1995a.
52. Pitchot W, Hansenne M, Gonzales Moreno A, Ansseu M. The dexamethasone suppression test in violent suicide attempters with major depression. Biol Psychiatry, 37: 273-4, 1995b.
53. Pitchot W, Hansenne M, Gonzalez Moreno A, Pinto E, Reggers J, Fuchs S, Pirard S, Ansseau M. Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology, 26: 689-96, 2001a.
54. Pitchot W, Hansenne M, Ansseau M. Role of dopamine in non-depressed patients with a history of suicide attempts. Eur Psychiatry, 16: 424-7, 2001b.
55. Pitchot W, Hansenne M, Pinto E, Reggers J, Fuchs S, Ansseau M. Alpha-2-adrenoreceptors in depressed suicide attempters: relationship with medical lethality of the attempt. Neuropsychobiology, 44: 91-4, 2001c.
56. Plocka-Lewandowska M, Araszkiewicz A, Rybakowski JK. Dexamethasone suppression test and suicide attempts in schizophrenic patients. Eur Psychiatry, 16: 428-31, 2001.
57. Rampello L, Nicoletti F, Nicoletti F. Dopamine and depression. CNS drugs, 13: 35-45, 2000.
58. Robbins DR, Alessi NE. Suicide and the dexamethasone suppression test in adolescence. Biol Psychiatry, 20: 107-10, 1985.
59. Roy A, Bissette G, Nemeroff CB, DeJong J, Ravitz B, Adinoff B, Linnoila M. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in alcoholics and normal controls. Biol Psychiatry, 28: 767-72, 1990.
60. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry, 32: 812-6, 1992.
61. Schmidtke A, Fleckenstein P, Beckmann H. The dexamethasone suppression test and suicide attempts. Acta Psychiatr Scand, 79: 276-82, 1989.
62. Siever LJ, Uhde TW. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha-2-adrenergic agonist clonidine. Biol Psychiatry, 19: 131-56, 1984.
63. Strickland PL, Deakin JF, Percival C, Dixon J, Gater RA, Goldberg DP. Bio-social origins of depression in the community: interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry, 180: 168-73, 2002.
64. Targum SD, Rosen L, Capodanno AE. The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry, 140: 877-9, 1983.
65. Valdivieso S, Duval F, Mockrani MC, Schaltebrand N, Castro JO, Crocq MA, Macher JP. Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients. Psychiatr Res, 60: 23-32, 1996.
66. Van Heeringen K, Audenaert K, Van de Wiele L, Verstraete A. Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J Affect Disord, 60: 181-9, 2000.
67. Young AH, Rue J, Odontiadis J, Cowen PJ. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release. Psychopharmacology (Berl), 136: 198-200, 1998.